secwatch.observer — SEC 8-K summary
======================================

Issuer:     LENSAR, Inc. (LNSR)
CIK:        0001320350
Form:       8-K
Filed at:   2026-05-29T20:05:15+00:00
Accession:  0001193125-26-248230
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02, 5.08, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

LENSAR appoints Michael A. Rossi as Interim CFO; annual meeting set for Aug 4, 2026
--------------------------------------------------------------------------------

- Michael A. Rossi appointed Interim CFO effective May 29, 2026, via consulting agreement with Monomoy Advisors at $375/hour.
- Rossi previously CFO at Access Vascular, ConcertAI, and Harvard Bioscience (Nasdaq: HBIO).
- Annual meeting scheduled for Aug 4, 2026, held virtually; record date June 10, 2026.
- Stockholder proposals and director nominations due by June 8, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320350/000119312526248230/0001193125-26-248230-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320350/000119312526248230/lnsr-20260525.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-248230

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer